Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients

• DOI: 10.1016/j.jcin.2022.04.010
• Publication Date: 2022-06-06T19:56:36Z
• Authors: Stephan Windecker; Azeem Latib; Elvin Kedhi; Ajay J. Kirtane; David E. Kandzari; Roxana Mehran; Matthew J. Price; Alexandre Abizaid; Daniel I. Simon; Stephen G. Worthley; Azfar Zaman; Martin Hudec; Petra Poliacikova; Abdul Kahar bin A...; Kamaraj Selvaraj; Ivo Petrov; Darren Mylotte; Eduardo Pinar; Raul Moreno; Franco Fabbiocchi; Sanjeevan Pasupati; Hyo-Soo Kim; Adel Aminian; Charles Tie; Adrian Wlodarczak; Seung-Ho Hur; Steven O. Marx; Ziad A. Ali; Maria Parke; Te-Hsin Lung; Gregg W. Stone
• Keywords: Clinical endpoint; Zotarolimus; Intention-to-treat analysis; Discontinuation